Pharmaceuticals & Biotech Swiss Community

Our community narratives are driven by numbers and valuation.

Value any stock for free in seconds

Get alerts and valuation updates

Participate in discussions

CHF 302.06
FV
3.0% overvalued intrinsic discount
5.07%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
about 1 month ago author updated this narrative
CHF 33.10
FV
44.9% undervalued intrinsic discount
11.03%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
7 months ago author updated this narrative
CHF 250.50
FV
29.4% undervalued intrinsic discount
6.44%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
2 days ago author updated this narrative
CHF 99.99
FV
1.4% undervalued intrinsic discount
1.91%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
6 days ago author updated this narrative
CHF 1.15k
FV
21.5% undervalued intrinsic discount
7.60%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
6 days ago author updated this narrative
CHF 662.24
FV
15.4% undervalued intrinsic discount
13.44%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
7 days ago author updated this narrative